Public comments needed, Celebrating national dosimetrist day, DEIinRO - Women in Leadership
August 21, 2024
| ASTRO 2024: Clinical Trials, Plenary and LBAs scheduled |
 |
| Key sessions from the Scientific Program have been scheduled. Clinical Trials, Plenary and Late-breaking Abstracts are now set! Add these items to your meeting schedule using the Annual Meeting Portal. The Clinical Trials and Plenary sessions showcase abstracts of scientific significance deemed to have the highest merit and greatest impact on radiation oncology research and practice. Late-breaking Abstracts are original research abstracts containing important late-breaking research results that were not available by the regular abstract submission deadline. You won’t want to miss these sessions! There’s still time to register to participate in person or virtually. |
| ASTRO 2024 private interview rooms |
| ASTRO offers private interview rooms for rent during the Annual Meeting. These rooms are ideal if you have multiple interviews to conduct or prefer to interview applicants in a private setting. A limited number of private interview rooms are available for three-hour periods. Email Todd Karstaedt for more information and to book in advance. |
| Extended deadline for public comments: August 26 |
| ASTRO seeks your feedback on two important draft documents. Please review and submit comments by Monday, August 26. Both can be accessed at www.astro.org/publiccomment or through the following individual links:
Quality and Safety Considerations for Radiopharmaceutical Therapy: An ASTRO Safety White Paper (draft). This consensus-based document focuses on the initiation and maintenance of a therapeutic radiopharmaceutical program in radiation oncology, workflow considerations, and quality and patient safety considerations. Draft DVH metrics for targets and normal tissues for six disease sites: lung, head and neck, breast, prostate, rectal and liver. Each disease site can be reviewed individually. |
| Today is National Medical Dosimetrist Day |
| Dosimetrists are critical members of the interdisciplinary radiation oncology clinical team and this day offers an opportunity to acknowledge their contributions. To celebrate dosimetry’s input to error prevention, RO-ILS shares a new de-identified “great catch” event in which dosimetry peer review identified an upstream error in the prescription. Additionally, three dosimetrists have been identified as safety stars and are being nationally recognized for their contributions to patient safety. Join us in congratulating these well-deserving dosimetrists and take this opportunity to thank and celebrate your dosimetry colleagues! |
| Task Force guideline on Hodgkin lymphoma application open |
| ASTRO is initiating a task force to develop the first ASTRO guideline on Radiation Therapy for Hodgkin lymphoma. To expand the pool of potential task force members, interested members may apply for consideration by Monday, September 2. We also encourage you to share this opportunity with any colleagues that would be interested. |
| Reminder: HP Fellow applications due September 13 |
| The Health Policy Fellowship is designed to provide exposure to ASTRO’s health policy reimbursement and coding activities and to develop the next generation of ASTRO health policy leaders. The year-long program provides the HP Fellow with a deeper understanding and subject matter expertise in code development and valuation, coding guidance, payer engagement and payment reform. Learn more and submit your application. |
| Join us for the next DEIinRO session – Women in Leadership | |
 |
The 2024 Diversity, Equity and Inclusion in Radiation Oncology (DEIinRO) social series will present Women in Leadership with Nancy Tarbell, MD, FASTRO, on September 5 at 12:00 p.m. Eastern time. In this free session, hosted by ASTRO’s Women in Radiation Oncology Affinity Group, Dr. Tarbell will provide tips on successful mentorship and advice on how to become an effective leader at one’s institution and in the field. Join us to learn more about Dr. Tarbell’s extraordinary career journey and pathway to becoming an ASTRO Gold Medalist. Register today! |
| Epic Users Webinar focused on the ASTRO/Epic collaboration |
| In collaboration with Epic, the ASTRO Communications Committee has begun working toward integrating radiation therapy-related patient educational material into their MyChart patient portal. The goal of this collaboration is to provide accurate and timely information as patients navigate their radiation oncology journey.
Join us for a webinar hosted by Epic’s Radiation Oncology Specialty Steering Board on September 5, 2:00 p.m. Central time, to learn more about the prostate cancer care companion, providing patients with education links and reminders in MyChart. You will need to have an Epic UserWeb account to be able to register for the webinar and access Epic documentation about the feature. Go to UserWeb.epic.com and follow the steps to log in, create an account, or get assistance. Learn more and register. |
| Patient spotlight: A survivor's Story |
| Discover Jeff White's inspiring journey as a tonsil cancer survivor in RTAnswers' latest Patient Stories. Jeff, ASTRO’s Director of Strategic Communications, shares valuable insight to ease the path for those facing a similar type of cancer. Explore his story and others from patients and caregivers. Share with your patients and encourage them to share their own story to offer hope and guidance to others. |
